| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |